Heartburn treatment in primary care: randomised, double blind study for 8 weeks (Q33648493)

28 July 2017

Heartburn treatment in primary care: randomised, double blind study for 8 weeks (English)

1 reference

28 July 2017

8

A Berstad

1 reference

28 July 2017

1

J G Hatlebakk

1 reference

28 July 2017

A Hyggen

2

1 reference

28 July 2017

P H Madsen

3

1 reference

28 July 2017

P O Walle

4

1 reference

28 July 2017

T Schulz

5

1 reference

28 July 2017

P Mowinckel

6

1 reference

28 July 2017

T Bernklev

7

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

28 July 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

The BMJ

1 reference

28 July 2017

319

1 reference

28 July 2017

7209

1 reference

28 July 2017

550-553

1 reference

Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Cisapride versus ranitidine in the treatment of reflux esophagitis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Effect of cisapride on postprandial gastro-oesophageal reflux

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Dyspepsia in England and Scotland

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Symptomatic gastroesophageal reflux: incidence and precipitating factors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Prokinetics in the treatment of gastro-oesophageal reflux disease. International symposium. Paris, France, 5 September 1996.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

The endoscopic assessment of esophagitis: a progress report on observer agreement.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Mechanisms of gastroesophageal reflux in ambulant healthy human subjects.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28208

Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10463897

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10463897

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.319.7209.550

1 reference

28 July 2017

1 reference

28 July 2017

1 reference